Q&A with Jagpreet Chhatwal, PhD, from Massachusetts General Hospital: Measuring Costs for Hepatitis C Treatment

Video

With more treatments on the market for hepatitis C, the costs of treatment have actually gone up in recent years. However, if more patients receive the care they need those costs could eventually go down.

With more treatments on the market for hepatitis C, the costs of treatment have actually gone up in recent years. However, if more patients receive the care they need those costs could eventually go down.

Jagpreet Chhatwal, PhD, from Massachusetts General Hospital, discussed recent research on the topic during the 2015 Liver Meeting in San Francisco. As part of the study, the researchers looked at the costs of treating those patients currently diagnosed with hepatitis C as well as what it would cost to make the condition a rare disease in the future.

Related Videos
Ankeet Bhatt, MD, MBA | Credit: X.com
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Andrew Talal, MD | Credit: University at Buffalo
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Veraprapas Kittipibul, MD | Credit: X.com
Andrew Talal, MD | Credit: University at Buffalo
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
© 2024 MJH Life Sciences

All rights reserved.